Key Takeaways
- • Private equity firms operate more than 500 healthcare facilities through nonprofit joint ventures, a largely opaque arrangement that has received minimal regulatory scrutiny compared to direct PE acquisitions of physician groups and specialty practices.
- • PE entities can hold controlling interests as high as 97% in nominally "nonprofit" hospital systems while maintaining the tax and regulatory benefits associated with nonprofit status, creating misalignment between profit motives and patient care priorities.
- • The Duke Lifepoint joint venture (2011)—a partnership between Apollo Global Management-backed Lifepoint Health and Duke University Health—exemplifies the structure: Apollo holds 97% controlling interest in the combined entity operating 153 hospitals, yet quality of care and patient safety metrics have declined since formation.
- • According to Ryan Leitner of the Private Equity Stakeholder Project, PE-backed joint ventures create structural incentives to maximize investor returns, potentially diverting resources from healthcare worker compensation and medical equipment investment to fund profit distributions.
- • The undercount of 500+ facilities suggests the true scale of PE penetration into nonprofit healthcare is substantially larger, as the figure captures only publicly identifiable arrangements and excludes opaque subsidiary structures.
Summary
Private equity firms have significantly expanded their influence in the nonprofit healthcare sector through joint venture structures that have largely escaped public and regulatory attention, according to a new report from the Private Equity Stakeholder Project (PESP) released July 7, 2026. While PE acquisitions of physician groups, specialty practices, and nursing homes have received substantial media coverage, nonprofit joint ventures represent a parallel and potentially larger channel through which PE capital is reshaping the healthcare delivery landscape.
The PESP report documents more than 500 healthcare facilities operated through these nonprofit joint ventures, though researchers acknowledge this represents an undercount based solely on publicly identifiable arrangements. The structural mechanics of these deals create significant opacity: private equity entities can maintain controlling ownership stakes—in some cases as high as 97%—while the joint venture entity retains nonprofit status and associated tax and regulatory privileges. This dual structure fundamentally misaligns the stated mission of nonprofit healthcare with PE investor return requirements.
The Duke Lifepoint joint venture serves as a principal case study. Formed in 2011 between Lifepoint Health (which operates 137 acute, rehabilitation, and behavioral health hospitals) and Duke University Health (16 hospitals), the structure places Apollo Global Management—Lifepoint's parent—in a 97% controlling position over the combined 153-hospital system. According to the PESP report, quality of care and patient safety metrics at Duke Lifepoint have declined materially since the 2011 combination, raising questions about the operational trade-offs inherent in PE-controlled healthcare delivery.
Ryan Leitner, PESP analyst, articulated the fundamental tension: "When these joint ventures are formed, the private equity-backed company has a motivation and even an obligation to investors to make a profit. That takes away resources for patient care, such as healthcare worker pay or investment in equipment." The report asserts that PE ownership of healthcare assets is empirically associated with elevated risks to both patients and healthcare providers. The scale of these arrangements—500+ facilities with likely undercounting—suggests PE influence in the nonprofit healthcare sector warrants heightened scrutiny from policymakers, institutional investors with ESG mandates, and fiduciaries overseeing healthcare-linked investments.
The PESP report documents more than 500 healthcare facilities operated through these nonprofit joint ventures, though researchers acknowledge this represents an undercount based solely on publicly identifiable arrangements. The structural mechanics of these deals create significant opacity: private equity entities can maintain controlling ownership stakes—in some cases as high as 97%—while the joint venture entity retains nonprofit status and associated tax and regulatory privileges. This dual structure fundamentally misaligns the stated mission of nonprofit healthcare with PE investor return requirements.
The Duke Lifepoint joint venture serves as a principal case study. Formed in 2011 between Lifepoint Health (which operates 137 acute, rehabilitation, and behavioral health hospitals) and Duke University Health (16 hospitals), the structure places Apollo Global Management—Lifepoint's parent—in a 97% controlling position over the combined 153-hospital system. According to the PESP report, quality of care and patient safety metrics at Duke Lifepoint have declined materially since the 2011 combination, raising questions about the operational trade-offs inherent in PE-controlled healthcare delivery.
Ryan Leitner, PESP analyst, articulated the fundamental tension: "When these joint ventures are formed, the private equity-backed company has a motivation and even an obligation to investors to make a profit. That takes away resources for patient care, such as healthcare worker pay or investment in equipment." The report asserts that PE ownership of healthcare assets is empirically associated with elevated risks to both patients and healthcare providers. The scale of these arrangements—500+ facilities with likely undercounting—suggests PE influence in the nonprofit healthcare sector warrants heightened scrutiny from policymakers, institutional investors with ESG mandates, and fiduciaries overseeing healthcare-linked investments.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.